Genetic modifiers of Huntington's disease.

@article{Gusella2014GeneticMO,
  title={Genetic modifiers of Huntington's disease.},
  author={James F. Gusella and Marcy E. MacDonald and Jong-Min Lee},
  journal={Movement disorders : official journal of the Movement Disorder Society},
  year={2014},
  volume={29 11},
  pages={
          1359-65
        }
}
Huntington's disease (HD) is a devastating neurodegenerative disorder that directly affects more than 1 in 10,000 persons in Western societies but, as a family disorder with a long, costly, debilitating course, it has an indirect impact on a far greater proportion of the population. Although some palliative treatments are used, no effective treatment exists for preventing clinical onset of the disorder or for delaying its inevitable progression toward premature death, approximately 15 years… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 35 CITATIONS

Huntington's disease: a clinical review.

  • European journal of neurology
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 60 REFERENCES

TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.

  • Biochemical and biophysical research communications
  • 2012
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2004
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

[Huntington's disease].

  • Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
  • 2014
VIEW 1 EXCERPT

Age, CAG repeat length, and clinical progression in Huntington's disease.

  • Movement disorders : official journal of the Movement Disorder Society
  • 2012

Similar Papers